Plain-English translation of NCT06864936 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This research study is exploring whether specialized eye imaging can show how well works in treating multiple sclerosis. Researchers will take detailed pictures of the back of your eye using a special camera (called OCT) to look for signs of immune system activity. The study hopes to discover new ways to measure whether this medication is helping control MS.
Currently, doctors measure MS treatment success using standard tests, but these don't always show the full picture of what's happening in the body. This trial aims to find a new, non-invasive way to track whether the medication is working by looking at immune activity visible in the eye.
You likely qualify if…
You likely don't qualify if…
If you join this study, you'll have specialized eye imaging scans at the start, at 6 months, and at 12 months. You may also complete some standard neurological tests that MS doctors routinely use to measure disease progression. The whole study lasts about one year, and your main responsibility is attending these three imaging visits at the University of Maryland MS center.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States